 | Eila Curlee SkinnerStanford University School of Medicine, Stanford, CA; | Department of Urology, Stanford University School of Medicine, Stanford, CA, USA | Department of Urology, Stanford ... |
KOL Resume for Eila Curlee Skinner (moderate, proteinenergy malnutrition, moderate, proteinenergy, moderate proteinenergy, malnutrition)
| Year | |
|---|---|
| 2022 | Stanford University School of Medicine, Stanford, CA; |
| 2021 | Department of Urology, Stanford University School of Medicine, Stanford, USA. Stanford University, Stanford, CA; |
| 2020 | Department of Urology, Stanford University, Stanford, CA. |
| 2019 | Department of Urology, Stanford University, Stanford, California. |
| 2018 | Department of Urology, Stanford University, Stanford, CA, USA |
| 2017 | Stanford Health Care; and Stanford Cancer Institute, Stanford, CA. Departments of Urology. |
| 2016 | From Stanford University School of Medicine, Stanford, CA. USC Keck School of Medicine, Institute of Urology, Los Angeles, CA Department of Urology and Stanford Cancer Institute, Stanford University, Stanford, California American Urological Association Education and Research, Inc., Linthicum, Maryland. |
| 2015 | Stanford, CA University of Southern California, Los Angeles, California, USA |
| 2014 | Authors' Affiliations: Departments of Urology and Preventive Medicine; Program in Genetic, Molecular, and Cellular Biology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Urology, School of Medicine, University of Stanford, Stanford, California Department of Urology, Stanford University, Stanford, CA |
| 2013 | USC Institute of Urology Norris Comprehensive Cancer Center Los Angeles California USA Stanford University, Stanford, California |
| 2012 | Los Angeles, CA Chairman and Waldbaum-Gardner Distinguished Professor, Smith Institute for Urology, Hofstra North Shore–LIJ School of Medicine, New York, New York Founders Professor of Urology, Perelman School of Medicine, University of Pennsylvania; Chief of Urology, Penn Medicine/University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania Stanford University Department of Urology, Stanford, California, USA Chief, Division of Surgical Innovation, Technology and Translation, Principal Investigator, Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Medical Center; Professor of Urology and Pediatrics, The George Washington University, Washington, DC |
| 2011 | USC Institute of Urology, University of Southern California, Los Angeles, CA, USA University of Southern California Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California |
| 2010 | University of Southern California, Los Angeles, California, USA, USC Institute of Urology, Keck School of Medicine, Los Angles, California, USA |
| 2008 | Department of Urology, Keck USC School of Medicine, 1441 Eastlake Ave, Suite 7416, MS 74, 90089, Los Angeles, CA, USA |
| 2007 | E Skinner is an Associate Professor of Clinical Urology at the Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Departments of Urology and Preventive Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California |
| 2006 | Department of Urology, University of Southern California, Los Angeles, CA, USA Keck School of Medicine at the University of Southern California, USC/Norris Comprehensive Cancer Center, Los Angeles, California |
| 2005 | Department of Urology, University of Southern California, Los Angeles, Los Angeles, CA 90089, USA |
| 2004 | From the Departments of Urology, Preventive Medicine (JC) and Medical Oncology (JP), Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California |
| 2003 | Department of Urology, Keck USC School of Medicine, Los Angeles, CA, USA |
| 2002 | Department of Urology, University of Southern California |
| 2001 | From the Departments of Urology, Medicine, Pathology, and Preventive Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA. |
| 1999 | Los Angeles, CA (Presented by Dr. Stein). |
| 1998 | Departments of Urology, Preventive Medicine, and Anesthesia, Kenneth Norris, Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, California |
Prominent publications by Eila Curlee Skinner
Systematic Review and Cumulative Analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Cystectomy
[ PUBLICATION ]
CONTEXT: Although open radical cystectomy (ORC) is still the standard approach, laparoscopic radical cystectomy (LRC) and robot-assisted radical cystectomy (RARC) have gained popularity.
OBJECTIVE: To report a systematic literature review and cumulative analysis of perioperative outcomes and complications of RARC in comparison with ORC and LRC.
EVIDENCE ACQUISITION: Medline, Scopus, and Web of Science databases were searched using a free-text protocol including the terms robot-assisted ...
| Known for Cumulative Analysis | Perioperative Outcomes | Radical Cystectomy | Blood Loss | Orc Rarc |
Transitional Cell Carcinoma Involving the Prostate with a Proposed Staging Classification for Stromal Invasion
[ PUBLICATION ]
PURPOSE: We investigated the effect on survival of transitional cell carcinoma of the prostatic urethra, ducts and stroma, and determined the difference between prostatic stromal involvement occurring via direct extension through the bladder wall versus stromal invasion arising intraurethrally.
MATERIALS AND METHODS: Between August 1971 and December 1989, 489 men underwent radical cystoprostatectomy for transitional cell carcinoma, including 143 (29.2%) identified with prostate ...
| Known for Stromal Invasion | Transitional Cell Carcinoma | Bladder Tumors | Prostate Involvement | Prostatic Urethra |
BACKGROUND: Radical cystectomy is the surgical standard for invasive bladder cancer. Robot-assisted cystectomy has been proposed to provide similar oncological outcomes with lower morbidity. We aimed to compare progression-free survival in patients with bladder cancer treated with open cystectomy and robot-assisted cystectomy.
METHODS: The RAZOR study is a randomised, open-label, non-inferiority, phase 3 trial done in 15 medical centres in the USA. Eligible participants (aged ≥18 years) ...
| Known for Robotic Cystectomy | Bladder Cancer | Assisted Radical | Patients Surgery | Inferiority Trial |
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
[ PUBLICATION ]
PURPOSE: To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node dissection for invasive bladder cancer and to describe the association of the primary bladder tumor stage and regional lymph node status with clinical outcomes.
PATIENTS AND METHODS: All patients undergoing radical cystectomy with bilateral pelvic iliac lymphadenectomy, with the intent to cure, for transitional-cell carcinoma of the bladder between July 1971 and ...
| Known for Radical Cystectomy | Invasive Bladder Cancer | Recurrence Patients | Transitional Cell Chemotherapy | Lymph Nodenegative Tumors |
PURPOSE: In an attempt to identify women who may be appropriate candidates for orthotopic lower urinary tract reconstruction, archival cystectomy specimens from female patients undergoing cystectomy for primary bladder cancer were reviewed. These pathological findings should provide a better understanding of tumor involvement at the bladder neck (vesicourethral junction) and urethra in women with transitional cell carcinoma of the bladder.
MATERIALS AND METHODS: Cystectomy specimens of ...
| Known for Bladder Cancer | Women Cystectomy | Pathological Review | Urinary Tract | Transitional Cell Carcinoma |
QUALITY OF LIFE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER IN PATIENTS WITH AN ILEAL CONDUIT, OR CUTANEOUS OR URETHRAL KOCK POUCH
[ PUBLICATION ]
PURPOSE: Radical cystectomy for bladder cancer is associated with many changes in bodily function with sexual and urinary dysfunction most prevalent. However, little research has been done on how efforts to improve erectile function relate to quality of life. Also, the psychological benefits associated with continent urinary diversion have not been fully explored. We compared long-term quality of life outcomes among 3 urinary diversion groups, and between patients who had and had not ...
| Known for Bladder Cancer | Quality Life | Radical Cystectomy | Ileal Conduit | Urinary Diversion |
Orthotopic Lower Urinary Tract Reconstruction in Women Using the Kock Ileal Neobladder: Updated Experience in 34 Patients
[ PUBLICATION ]
PURPOSE: Orthotopic lower urinary tract reconstruction has revolutionized urinary diversion following cystectomy. Initially performed solely in male patients, orthotopic diversion has now become a viable option in women. Currently, the orthotopic neobladder is the diversion of choice for women requiring lower urinary tract reconstruction at our institution. We evaluate and update our clinical and functional experience with orthotopic reconstruction in female patients.
MATERIALS AND ...
| Known for Orthotopic Diversion | Women Cystectomy | Urinary Tract | Proximal Urethra | Transitional Cell Carcinoma |
Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids
[ PUBLICATION ]
OBJECTIVES: It is well established that prostate cancer patients undergoing radical prostatectomy may experience disruptive side effects, most notably urinary incontinence and erectile dysfunction. The purpose of this study is to compare relevant outcomes between patients awaiting radical prostatectomy for prostate cancer and patients who already underwent the surgery, taking into account type of prostatectomy and use of erectile aids.
METHODS: We compared self-reports of global quality ...
| Known for Radical Prostatectomy | Erectile Aids | Prostate Cancer | Sexuality Patients | Quality Life |
Factors influencing post‐recurrence survival in bladder cancer following radical cystectomy
[ PUBLICATION ]
OBJECTIVE: To identify prognostic indicators that influence post-recurrence survival following radical cystectomy for bladder cancer.
PATIENTS AND METHODS: In all, 2029 patients with bladder cancer underwent radical cystectomy with intent to cure between 1971 and 2005 at our institution. Of these, 447 patients (22%) developed non-urinary tract recurrence and were chosen for further analysis. Clinicopathological characteristics were analysed by univariate and multivariate analysis to ...
| Known for Recurrence Survival | Bladder Cancer | Radical Cystectomy | Pathological Stage | Urinary Diversion |
The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
[ PUBLICATION ]
PURPOSE: The role of adjuvant chemotherapy for patients with high-risk urothelial carcinoma of the bladder (UCB) is not well defined. Here we address the value of adjuvant chemotherapy in patients undergoing radical cystectomy for UCB in an off-protocol routine clinical setting.
EXPERIMENTAL DESIGN: We collected and analyzed data from 11 centers contributing retrospective cohorts of patients with UCB treated with radical cystectomy without neoadjuvant chemotherapy. Patients were grouped ...
| Known for Adjuvant Chemotherapy | Urinary Bladder | Urothelial Carcinoma | Patients Ucb | Hazard Ratio |
Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction
[ PUBLICATION ]
BACKGROUND: Many patients with aggressive clinically superficial bladder cancer ultimately die of their cancer, due in part to resistance to undergo radical cystectomy. Radical cystectomy is usually curative for patients with pathologic superficial tumors. Orthotopic urinary reconstruction has lessened the morbidity and lifestyle changes in patients after cystectomy, and may increase patient acceptance of cystectomy as therapy for high risk superficial tumors.
METHODS: A retrospective ...
| Known for Radical Cystectomy | Superficial Bladder | Pathologic Upstaging | Orthotopic Urinary | Retrospective Analysis |
PROGNOSTIC SIGNIFICANCE OF LYMPHOVASCULAR INVASION OF BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY
[ PUBLICATION ]
PURPOSE: We determined the prognostic significance of lymphovascular invasion (LVI) in patients treated for invasive transitional cell carcinoma of the bladder with radical cystectomy.
MATERIALS AND METHODS: From August 1971 to June 2004, 2,005 patients underwent radical cystectomy for primary bladder cancer with intent to cure. All patients with nontransitional cell carcinoma histology, palliative procedures, unknown lymphovascular status, less than pT1 pathological stage, or any ...
| Known for Radical Cystectomy | Prognostic Significance | Patients Lvi | Lymphovascular Invasion | Bladder Cancer |
PURPOSE: We describe the rate of up staging and the cancer specific outcomes of patients with carcinoma in situ refractory to transurethral resection with intravesical therapy treated with radical cystectomy.
MATERIALS AND METHODS: The records of 3,207 patients treated with radical cystectomy for urothelial carcinoma of the bladder at 8 centers in the United States, Canada and Europe were reviewed.
RESULTS: Of the 3,207 patients who underwent radical cystectomy 243 (7.6%) had clinical ...
| Known for Radical Cystectomy | Carcinoma Situ | Disease Recurrence | Lymphovascular Invasion | Cancer Specific Mortality |
BACKGROUND: The authors evaluated the experiences at their institution with radical cystectomy and urinary diversion performed on elderly bladder carcinoma patients to determine whether age had an impact on the clinical or functional results for this group of patients.
METHODS: Between August 1971 and December 1996, 404 patients age 70 years or older (median age, 74 years) underwent radical cystectomy and urinary diversion for invasive bladder carcinoma: 352 (87%) were ages 70-79 years ...
| Known for Radical Cystectomy | 70 Years | Bladder Carcinoma | Urinary Diversion | Elderly Patients |
BACKGROUND: Nephron-sparing surgery (NSS) can safely be performed with slightly higher complication rates than radical nephrectomy (RN), but proof of oncologic effectiveness is lacking.
OBJECTIVE: To compare overall survival (OS) and time to progression.
DESIGN, SETTING, AND PARTICIPANTS: From March 1992 to January 2003, when the study was prematurely closed because of poor accrual, 541 patients with small (≤5 cm), solitary, T1-T2 N0 M0 (Union Internationale Contre le Cancer [UICC] 1978) ...
| Known for Radical Nephrectomy | Oncologic Outcome | Renal Cancer | Cell Carcinoma | Rcc Patients |
Eila Curlee Skinner: Influence Statistics
| Concept | World rank |
|---|---|
| superextended dissection | #1 |
| median cystectomy | #1 |
| 001 cystectomy | #1 |
| bloc specimens | #1 |
| 1476 radical | #1 |
| residual pin adt | #1 |
| ucb glandular | #1 |
| gc vac | #1 |
| ucb patients patients | #1 |
| bladder cystectomy | #1 |
| median time pros | #1 |
| cta lnm | #1 |
| robotic approaches summary | #1 |
| diversion pt4a | #1 |
| differentiation multivariable analysis | #1 |
| upper tract urethra | #1 |
| nmibc pathologic | #1 |
| cystectomy pros | #1 |
| stay sb | #1 |
| vaginal fistula formation | #1 |
| src recurrent | #1 |
| lnpositive disease | #1 |
| knn51 patients | #1 |
| commonly forms approaches | #1 |
| cystoprostatectomy male | #1 |
| precystectomy decision | #1 |
| pathologic nmibc | #1 |
| muc survival | #1 |
| recurrence upper tract | #1 |
| primary tgcts histology | #1 |
| underwent superextended | #1 |
| deep pt2b | #1 |
| 152 patients cystectomy | #1 |
| sb 19 ± | #1 |
| neobladder reconstruction | #1 |
| studies international consultation | #1 |
| salvage radical cystectomy | #1 |
| balanced casecontrol approach | #1 |
| radical cystectomy decades | #1 |
| findings clinical benefits | #1 |
| patients ctis | #1 |
| patients dose sb | #1 |
| ucb outcomes males | #1 |
| clinical stage lnm | #1 |
| propensity scorematched cohorts | #1 |
| influencing post‐recurrence | #1 |
| cases differentiation | #1 |
| postoperative day sb | #1 |
| pin regression | #1 |
| prognostic factors src | #1 |
Open the FULL List in Excel | |
Key People For Radical Cystectomy
Eila Curlee Skinner:Expert Impact
Concepts for whichEila Curlee Skinnerhas direct influence:Radical cystectomy, Bladder cancer, Urinary diversion, Prostate cancer, Stromal invasion, Lymph node, Partial nephrectomy, Urothelial carcinoma.
Eila Curlee Skinner:KOL impact
Concepts related to the work of other authors for whichfor which Eila Curlee Skinner has influence:Bladder cancer, Radical cystectomy, Urothelial carcinoma, Urinary diversion, Partial nephrectomy, Neoadjuvant chemotherapy, Lymph node.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |